Skip to content
2000
image of MOTS-c as a Potential Diagnostic-prognostic Biomarker for Myocardial Infarction

Abstract

Background

Myocardial infarction (MI) is a disease characterised by myocardial necrosis due to acute and prolonged ischaemic hypoxia in the coronary arteries. MOTS-c is a mitochondrial-derived peptide that has been reported to have protective effects on cardiac tissue. Although this peptide is thought to be decreased in various diseases and can serve as a potential biomarker, current studies remain limited.

Objective

This study aimed to evaluate how the post-treatment process affects circulating MOTS-c peptide levels in myocardial infarction patients.

Methods

For this purpose, patients without obstructive coronary lesions on angiography were included in the control group, while those with significant obstructive coronary lesions on angiography were included in the infarction group. Routine biochemistry tests were performed using an autoanalyzer. Besides, serum MOTS-c levels were measured using ELISA.

Results

Our findings showed CRP, ESR, and troponin I levels to be higher in the MI group compared to the control group. Also, there was no significant change in MOTS-c levels between the control and the MI group, while time-dependent changes (day 0, day 3, and day 30) occurred within the MI group. However, a negative correlation was found between MOTS-c and platelet levels in the MI group at day 0 (r: -0.4417, =0.0450). Similarly, MOTS-c was found to be negatively correlated with troponin I in the MI group at day 3 (r: -0.4571, =0.0372).

Conclusion

The negative correlation of MOTS-c level with both platelet and troponin I has shown that this peptide may contribute to the diagnostic and therapeutic evaluation of the MI process along with other parameters.

Loading

Article metrics loading...

/content/journals/chamc/10.2174/0118715257368076250324041741
2025-05-09
2025-09-17
Loading full text...

Full text loading...

References

  1. Diehm C. Lange S. Darius H. Pittrow D. von Stritzky B. Tepohl G. Haberl R.L. Allenberg J.R. Dasch B. Trampisch H.J. Association of low ankle brachial index with high mortality in primary care. Eur. Heart J. 2006 27 14 1743 1749 10.1093/eurheartj/ehl092 16782720
    [Google Scholar]
  2. Roth G.A. Mensah G.A. Johnson C.O. Addolorato G. Ammirati E. Baddour L.M. Barengo N.C. Beaton A.Z. Benjamin E.J. Benziger C.P. Bonny A. Brauer M. Brodmann M. Cahill T.J. Carapetis J. Catapano A.L. Chugh S.S. Cooper L.T. Coresh J. Criqui M. DeCleene N. Eagle K.A. Emmons-Bell S. Feigin V.L. Fernández-Solà J. Fowkes G. Gakidou E. Grundy S.M. He F.J. Howard G. Hu F. Inker L. Karthikeyan G. Kassebaum N. Koroshetz W. Lavie C. Lloyd-Jones D. Lu H.S. Mirijello A. Temesgen A.M. Mokdad A. Moran A.E. Muntner P. Narula J. Neal B. Ntsekhe M. Moraes de Oliveira G. Otto C. Owolabi M. Pratt M. Rajagopalan S. Reitsma M. Ribeiro A.L.P. Rigotti N. Rodgers A. Sable C. Shakil S. Sliwa-Hahnle K. Stark B. Sundström J. Timpel P. Tleyjeh I.M. Valgimigli M. Vos T. Whelton P.K. Yacoub M. Zuhlke L. Murray C. Fuster V. Roth G.A. Mensah G.A. Johnson C.O. Addolorato G. Ammirati E. Baddour L.M. Barengo N.C. Beaton A. Benjamin E.J. Benziger C.P. Bonny A. Brauer M. Brodmann M. Cahill T.J. Carapetis J.R. Catapano A.L. Chugh S. Cooper L.T. Coresh J. Criqui M.H. DeCleene N.K. Eagle K.A. Emmons-Bell S. Feigin V.L. Fernández-Sola J. Fowkes F.G.R. Gakidou E. Grundy S.M. He F.J. Howard G. Hu F. Inker L. Karthikeyan G. Kassebaum N.J. Koroshetz W.J. Lavie C. Lloyd-Jones D. Lu H.S. Mirijello A. Misganaw A.T. Mokdad A.H. Moran A.E. Muntner P. Narula J. Neal B. Ntsekhe M. Oliveira G.M.M. Otto C.M. Owolabi M.O. Pratt M. Rajagopalan S. Reitsma M.B. Ribeiro A.L.P. Rigotti N.A. Rodgers A. Sable C.A. Shakil S.S. Sliwa K. Stark B.A. Sundström J. Timpel P. Tleyjeh I.I. Valgimigli M. Vos T. Whelton P.K. Yacoub M. Zuhlke L.J. Abbasi-Kangevari M. Abdi A. Abedi A. Aboyans V. Abrha W.A. Abu-Gharbieh E. Abushouk A.I. Acharya D. Adair T. Adebayo O.M. Ademi Z. Advani S.M. Afshari K. Afshin A. Agarwal G. Agasthi P. Ahmad S. Ahmadi S. Ahmed M.B. Aji B. Akalu Y. Akande-Sholabi W. Aklilu A. Akunna C.J. Alahdab F. Al-Eyadhy A. Alhabib K.F. Alif S.M. Alipour V. Aljunid S.M. Alla F. Almasi-Hashiani A. Almustanyir S. Al-Raddadi R.M. Amegah A.K. Amini S. Aminorroaya A. Amu H. Amugsi D.A. Ancuceanu R. Anderlini D. Andrei T. Andrei C.L. Ansari-Moghaddam A. Anteneh Z.A. Antonazzo I.C. Antony B. Anwer R. Appiah L.T. Arabloo J. Ärnlöv J. Artanti K.D. Ataro Z. Ausloos M. Avila-Burgos L. Awan A.T. Awoke M.A. Ayele H.T. Ayza M.A. Azari S. B D.B. Baheiraei N. Baig A.A. Bakhtiari A. Banach M. Banik P.C. Baptista E.A. Barboza M.A. Barua L. Basu S. Bedi N. Béjot Y. Bennett D.A. Bensenor I.M. Berman A.E. Bezabih Y.M. Bhagavathula A.S. Bhaskar S. Bhattacharyya K. Bijani A. Bikbov B. Birhanu M.M. Boloor A. Brant L.C. Brenner H. Briko N.I. Butt Z.A. Caetano dos Santos F.L. Cahill L.E. Cahuana-Hurtado L. Cámera L.A. Campos-Nonato I.R. Cantu-Brito C. Car J. Carrero J.J. Carvalho F. Castañeda-Orjuela C.A. Catalá-López F. Cerin E. Charan J. Chattu V.K. Chen S. Chin K.L. Choi J-Y.J. Chu D-T. Chung S-C. Cirillo M. Coffey S. Conti S. Costa V.M. Cundiff D.K. Dadras O. Dagnew B. Dai X. Damasceno A.A.M. Dandona L. Dandona R. Davletov K. De la Cruz-Góngora V. De la Hoz F.P. De Neve J-W. Denova-Gutiérrez E. Derbew Molla M. Derseh B.T. Desai R. Deuschl G. Dharmaratne S.D. Dhimal M. Dhungana R.R. Dianatinasab M. Diaz D. Djalalinia S. Dokova K. Douiri A. Duncan B.B. Duraes A.R. Eagan A.W. Ebtehaj S. Eftekhari A. Eftekharzadeh S. Ekholuenetale M. El Nahas N. Elgendy I.Y. Elhadi M. El-Jaafary S.I. Esteghamati S. Etisso A.E. Eyawo O. Fadhil I. Faraon E.J.A. Faris P.S. Farwati M. Farzadfar F. Fernandes E. Fernandez Prendes C. Ferrara P. Filip I. Fischer F. Flood D. Fukumoto T. Gad M.M. Gaidhane S. Ganji M. Garg J. Gebre A.K. Gebregiorgis B.G. Gebregzabiher K.Z. Gebremeskel G.G. Getacher L. Obsa A.G. Ghajar A. Ghashghaee A. Ghith N. Giampaoli S. Gilani S.A. Gill P.S. Gillum R.F. Glushkova E.V. Gnedovskaya E.V. Golechha M. Gonfa K.B. Goudarzian A.H. Goulart A.C. Guadamuz J.S. Guha A. Guo Y. Gupta R. Hachinski V. Hafezi-Nejad N. Haile T.G. Hamadeh R.R. Hamidi S. Hankey G.J. Hargono A. Hartono R.K. Hashemian M. Hashi A. Hassan S. Hassen H.Y. Havmoeller R.J. Hay S.I. Hayat K. Heidari G. Herteliu C. Holla R. Hosseini M. Hosseinzadeh M. Hostiuc M. Hostiuc S. Househ M. Huang J. Humayun A. Iavicoli I. Ibeneme C.U. Ibitoye S.E. Ilesanmi O.S. Ilic I.M. Ilic M.D. Iqbal U. Irvani S.S.N. Islam S.M.S. Islam R.M. Iso H. Iwagami M. Jain V. Javaheri T. Jayapal S.K. Jayaram S. Jayawardena R. Jeemon P. Jha R.P. Jonas J.B. Jonnagaddala J. Joukar F. Jozwiak J.J. Jürisson M. Kabir A. Kahlon T. Kalani R. Kalhor R. Kamath A. Kamel I. Kandel H. Kandel A. Karch A. Kasa A.S. Katoto P.D.M.C. Kayode G.A. Khader Y.S. Khammarnia M. Khan M.S. Khan M.N. Khan M. Khan E.A. Khatab K. Kibria G.M.A. Kim Y.J. Kim G.R. Kimokoti R.W. Kisa S. Kisa A. Kivimäki M. Kolte D. Koolivand A. Korshunov V.A. Koulmane Laxminarayana S.L. Koyanagi A. Krishan K. Krishnamoorthy V. Kuate Defo B. Kucuk Bicer B. Kulkarni V. Kumar G.A. Kumar N. Kurmi O.P. Kusuma D. Kwan G.F. La Vecchia C. Lacey B. Lallukka T. Lan Q. Lasrado S. Lassi Z.S. Lauriola P. Lawrence W.R. Laxmaiah A. LeGrand K.E. Li M-C. Li B. Li S. Lim S.S. Lim L-L. Lin H. Lin Z. Lin R-T. Liu X. Lopez A.D. Lorkowski S. Lotufo P.A. Lugo A. M N.K. Madotto F. Mahmoudi M. Majeed A. Malekzadeh R. Malik A.A. Mamun A.A. Manafi N. Mansournia M.A. Mantovani L.G. Martini S. Mathur M.R. Mazzaglia G. Mehata S. Mehndiratta M.M. Meier T. Menezes R.G. Meretoja A. Mestrovic T. Miazgowski B. Miazgowski T. Michalek I.M. Miller T.R. Mirrakhimov E.M. Mirzaei H. Moazen B. Moghadaszadeh M. Mohammad Y. Mohammad D.K. Mohammed S. Mohammed M.A. Mokhayeri Y. Molokhia M. Montasir A.A. Moradi G. Moradzadeh R. Moraga P. Morawska L. Moreno Velásquez I. Morze J. Mubarik S. Muruet W. Musa K.I. Nagarajan A.J. Nalini M. Nangia V. Naqvi A.A. Narasimha Swamy S. Nascimento B.R. Nayak V.C. Nazari J. Nazarzadeh M. Negoi R.I. Neupane Kandel S. Nguyen H.L.T. Nixon M.R. Norrving B. Noubiap J.J. Nouthe B.E. Nowak C. Odukoya O.O. Ogbo F.A. Olagunju A.T. Orru H. Ortiz A. Ostroff S.M. Padubidri J.R. Palladino R. Pana A. Panda-Jonas S. Parekh U. Park E-C. Parvizi M. Pashazadeh Kan F. Patel U.K. Pathak M. Paudel R. Pepito V.C.F. Perianayagam A. Perico N. Pham H.Q. Pilgrim T. Piradov M.A. Pishgar F. Podder V. Polibin R.V. Pourshams A. Pribadi D.R.A. Rabiee N. Rabiee M. Radfar A. Rafiei A. Rahim F. Rahimi-Movaghar V. Ur Rahman M.H. Rahman M.A. Rahmani A.M. Rakovac I. Ram P. Ramalingam S. Rana J. Ranasinghe P. Rao S.J. Rathi P. Rawal L. Rawasia W.F. Rawassizadeh R. Remuzzi G. Renzaho A.M.N. Rezapour A. Riahi S.M. Roberts-Thomson R.L. Roever L. Rohloff P. Romoli M. Roshandel G. Rwegerera G.M. Saadatagah S. Saber-Ayad M.M. Sabour S. Sacco S. Sadeghi M. Saeedi Moghaddam S. Safari S. Sahebkar A. Salehi S. Salimzadeh H. Samaei M. Samy A.M. Santos I.S. Santric-Milicevic M.M. Sarrafzadegan N. Sarveazad A. Sathish T. Sawhney M. Saylan M. Schmidt M.I. Schutte A.E. Senthilkumaran S. Sepanlou S.G. Sha F. Shahabi S. Shahid I. Shaikh M.A. Shamali M. Shamsizadeh M. Shawon M.S.R. Sheikh A. Shigematsu M. Shin M-J. Shin J.I. Shiri R. Shiue I. Shuval K. Siabani S. Siddiqi T.J. Silva D.A.S. Singh J.A. Mtech A.S. Skryabin V.Y. Skryabina A.A. Soheili A. Spurlock E.E. Stockfelt L. Stortecky S. Stranges S. Suliankatchi Abdulkader R. Tadbiri H. Tadesse E.G. Tadesse D.B. Tajdini M. Tariqujjaman M. Teklehaimanot B.F. Temsah M-H. Tesema A.K. Thakur B. Thankappan K.R. Thapar R. Thrift A.G. Timalsina B. Tonelli M. Touvier M. Tovani-Palone M.R. Tripathi A. Tripathy J.P. Truelsen T.C. Tsegay G.M. Tsegaye G.W. Tsilimparis N. Tusa B.S. Tyrovolas S. Umapathi K.K. Unim B. Unnikrishnan B. Usman M.S. Vaduganathan M. Valdez P.R. Vasankari T.J. Velazquez D.Z. Venketasubramanian N. Vu G.T. Vujcic I.S. Waheed Y. Wang Y. Wang F. Wei J. Weintraub R.G. Weldemariam A.H. Westerman R. Winkler A.S. Wiysonge C.S. Wolfe C.D.A. Wubishet B.L. Xu G. Yadollahpour A. Yamagishi K. Yan L.L. Yandrapalli S. Yano Y. Yatsuya H. Yeheyis T.Y. Yeshaw Y. Yilgwan C.S. Yonemoto N. Yu C. Yusefzadeh H. Zachariah G. Zaman S.B. Zaman M.S. Zamanian M. Zand R. Zandifar A. Zarghi A. Zastrozhin M.S. Zastrozhina A. Zhang Z-J. Zhang Y. Zhang W. Zhong C. Zou Z. Zuniga Y.M.H. Murray C.J.L. Fuster V. GBD-NHLBI-JACC Global Burden of Cardiovascular Diseases Writing Group Global burden of cardiovascular diseases and risk factors, 1990–2019: Update from the GBD 2019 study. J. Am. Coll. Cardiol. 2020 76 25 2982 3021 10.1016/j.jacc.2020.11.010 33309175
    [Google Scholar]
  3. İstatistikleri T.A. Index 2019
    [Google Scholar]
  4. Anderson J.L. Morrow D.A. Acute myocardial infarction. N. Engl. J. Med. 2017 376 21 2053 2064 10.1056/NEJMra1606915 28538121
    [Google Scholar]
  5. Mozaffarian D. Benjamin E.J. Go A.S. Arnett D.K. Blaha M.J. Cushman M. De Ferranti S. Després J.-P. Fullerton H.J. Howard V.J. Heart disease and stroke statistics—2015 update: A report from the american heart association. Circulation 2015 131 4 e329 e322
    [Google Scholar]
  6. Antman E.M. Acute myocardial infarction. Heart disease-A Textbook os Dardiovascular Medicine 1997 1184 1228
    [Google Scholar]
  7. Chen Z. Venkat P. Seyfried D. Chopp M. Yan T. Chen J. Brain–heart interaction. Circ. Res. 2017 121 4 451 468 10.1161/CIRCRESAHA.117.311170 28775014
    [Google Scholar]
  8. Populations B.H.S. Criteria C.S.S.H.D. HIV and disability: Updating the social security listings. National Academies Press 2010
    [Google Scholar]
  9. Bink N. Mohan V.B. Fakirov S. Recent advances in plastic stents: A comprehensive review. Int. J. Polym. Mater. 2021 70 1 54 74 10.1080/00914037.2019.1685519
    [Google Scholar]
  10. Hamm C.W. Bassand J.P. Agewall S. Bax J. Boersma E. Bueno H. Caso P. Dudek D. Gielen S. Huber K. Ohman M. Petrie M.C. Sonntag F. Uva M.S. Storey R.F. Wijns W. Zahger D. European Society of Cardiology ESC guidelines for the management of acute coronary syndromes in patients without persistent ST-segment elevation at presentation. Task force for the management of acute coronary syndromes (ACS) in patients without persistent st-segment elevation at presentation of the european society of cardiology (ESC). G. Ital. Cardiol. 2012 13 3 171 228 22395108
    [Google Scholar]
  11. Reyes-Retana J.A. Duque-Ossa L.C. Acute myocardial infarction biosensor: A review from bottom up. Curr. Probl. Cardiol. 2021 46 3 100739 10.1016/j.cpcardiol.2020.100739 33250264
    [Google Scholar]
  12. Procopio A. De Rosa S. Covello C. Merola A. Sabatino J. De Luca A. Indolfi C. Amato F. Cosentino C. 2019 18th European Control Conference (ECC) 2019, pp 1653-1658.
    [Google Scholar]
  13. Garg P. Morris P. Fazlanie A.L. Vijayan S. Dancso B. Dastidar A.G. Plein S. Mueller C. Haaf P. Cardiac biomarkers of acute coronary syndrome: From history to high-sensitivity cardiac troponin. Intern. Emerg. Med. 2017 12 2 147 155 10.1007/s11739‑017‑1612‑1 28188579
    [Google Scholar]
  14. Bostan M.M. Stătescu C. Anghel L. Șerban I.L. Cojocaru E. Sascău R. Post-myocardial infarction ventricular remodeling biomarkers—the key link between pathophysiology and clinic. Biomolecules 2020 10 11 1587 10.3390/biom10111587 33238444
    [Google Scholar]
  15. Hashimoto Y. Niikura T. Tajima H. Yasukawa T. Sudo H. Ito Y. Kita Y. Kawasumi M. Kouyama K. Doyu M. Sobue G. Koide T. Tsuji S. Lang J. Kurokawa K. Nishimoto I. A rescue factor abolishing neuronal cell death by a wide spectrum of familial Alzheimer’s disease genes and Aβ. Proc. Natl. Acad. Sci. USA 2001 98 11 6336 6341 10.1073/pnas.101133498 11371646
    [Google Scholar]
  16. Lee C. Zeng J. Drew B.G. Sallam T. Martin-Montalvo A. Wan J. Kim S.J. Mehta H. Hevener A.L. de Cabo R. Cohen P. The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance. Cell Metab. 2015 21 3 443 454 10.1016/j.cmet.2015.02.009 25738459
    [Google Scholar]
  17. Kim S.J. Xiao J. Wan J. Cohen P. Yen K. Mitochondrially derived peptides as novel regulators of metabolism. J. Physiol. 2017 595 21 6613 6621 10.1113/JP274472 28574175
    [Google Scholar]
  18. Ramanjaneya M. Bettahi I. Jerobin J. Chandra P. Abi Khalil C. Skarulis M. Atkin S.L. Abou-Samra A.B. Mitochondrial-derived peptides are down regulated in diabetes subjects. Front. Endocrinol. 2019 10 331 10.3389/fendo.2019.00331 31214116
    [Google Scholar]
  19. Yazgan B. Türkel İ. Özerkliğ B. Atakan M.M. Aktitiz S. Koşar Ş.N. Exercise and metabolic health: The emerging roles of novel exerkines. Curr. Protein Pept. Sci. 2022 23 7 437 455 10.2174/1389203723666220629163524 35770405
    [Google Scholar]
  20. Atakan M.M. Türkel İ. Özerkliğ B. Koşar Ş.N. Taylor D.F. Yan X. Bishop D.J. Small peptides: Could they have a big role in metabolism and the response to exercise? J. Physiol. 2024 602 4 545 568 10.1113/JP283214 38196325
    [Google Scholar]
  21. Merry T.L. Chan A. Woodhead J.S.T. Reynolds J.C. Kumagai H. Kim S.J. Lee C. Mitochondrial-derived peptides in energy metabolism. Am. J. Physiol. Endocrinol. Metab. 2020 319 4 E659 E666 10.1152/ajpendo.00249.2020 32776825
    [Google Scholar]
  22. Yong C.Q.Y. Tang B.L. A mitochondrial encoded messenger at the nucleus. Cells 2018 7 8 105 10.3390/cells7080105 30104535
    [Google Scholar]
  23. Rochette L. Meloux A. Zeller M. Cottin Y. Vergely C. Role of humanin, a mitochondrial-derived peptide, in cardiovascular disorders. Arch. Cardiovasc. Dis. 2020 113 8-9 564 571 10.1016/j.acvd.2020.03.020 32680738
    [Google Scholar]
  24. Dabravolski S.A. Nikiforov N.G. Starodubova A.V. Popkova T.V. Orekhov A.N. The role of mitochondria-derived peptides in cardiovascular diseases and their potential as therapeutic targets. Int. J. Mol. Sci. 2021 22 16 8770 10.3390/ijms22168770 34445477
    [Google Scholar]
  25. Cao X. Li H. Tao H. Wu N. Yu L. Zhang D. Lu X. Zhu J. Lu Z. Zhu Q. Metformin inhibits vascular calcification in female rat aortic smooth muscle cells via the AMPK-eNOS-NO pathway. Endocrinology 2013 154 10 3680 3689 10.1210/en.2013‑1002 24025223
    [Google Scholar]
  26. Li Y. Li Z. Ren Y. Lei Y. Yang S. Shi Y. Peng H. Yang W. Guo T. Yu Y. Xiong Y. Mitochondrial-derived peptides in cardiovascular disease: Novel insights and therapeutic opportunities. J. Adv. Res. 2024 64 99 115 10.1016/j.jare.2023.11.018 38008175
    [Google Scholar]
  27. Wei M. Gan L. Liu Z. Liu L. Chang J.R. Yin D.C. Cao H.L. Su X.L. Smith W.W. Mitochondrial-derived peptide MOTS-c attenuates vascular calcification and secondary myocardial remodeling via adenosine monophosphate-activated protein kinase signaling pathway. Cardiorenal Med. 2020 10 1 42 50 10.1159/000503224 31694019
    [Google Scholar]
  28. Qin Q. Delrio S. Wan J. Jay Widmer R. Cohen P. Lerman L.O. Lerman A. Downregulation of circulating MOTS-c levels in patients with coronary endothelial dysfunction. Int. J. Cardiol. 2018 254 23 27 10.1016/j.ijcard.2017.12.001 29242099
    [Google Scholar]
  29. Park K.H. Park W.J. Endothelial dysfunction: Clinical implications in cardiovascular disease and therapeutic approaches. J. Korean Med. Sci. 2015 30 9 1213 1225 10.3346/jkms.2015.30.9.1213 26339159
    [Google Scholar]
  30. Li H. Ren K. Jiang T. Zhao G.J. MOTS-c attenuates endothelial dysfunction via suppressing the MAPK/NF-κB pathway. Int. J. Cardiol. 2018 268 40 10.1016/j.ijcard.2018.03.031 30041797
    [Google Scholar]
  31. Available from: https://www.who.int/newsroom/fact-sheets/detail/cardiovascular-diseases-(cvds)
  32. Aydin S. Ugur K. Aydin S. Sahin İ. Yardim M. Biomarkers in acute myocardial infarction: Current perspectives. Vasc. Health Risk Manag. 2019 15 1 10 10.2147/VHRM.S166157 30697054
    [Google Scholar]
  33. Ross R. Atherosclerosis--an inflammatory disease. N. Engl. J. Med. 1999 340 2 115 126 10.1056/NEJM199901143400207 9887164
    [Google Scholar]
  34. Palmerini T. Marzocchi A. Marrozzini C. Ortolani P. Saia F. Bacchi-Reggiani L. Virzì S. Gianstefani S. Branzi A. Preprocedural levels of C-reactive protein and leukocyte counts predict 9-month mortality after coronary angioplasty for the treatment of unprotected left main coronary artery stenosis. Circulation 2005 112 15 2332 2338 10.1161/CIRCULATIONAHA.105.551648 16203907
    [Google Scholar]
  35. Olenchock B.A. Wiviott S.D. Murphy S.A. Cannon C.P. Rifai N. Braunwald E. Morrow D.A. Lack of association between soluble CD40L and risk in a large cohort of patients with acute coronary syndrome in OPUS TIMI-16. J. Thromb. Thrombolysis 2008 26 2 79 84 10.1007/s11239‑007‑0156‑z 17917707
    [Google Scholar]
  36. Armstrong E.J. Morrow D.A. Sabatine M.S. Inflammatory biomarkers in acute coronary syndromes: Part I: Introduction and cytokines. Circulation 2006 113 6 e72 e75 10.1161/CIRCULATIONAHA.105.595520 16476853
    [Google Scholar]
  37. Roman R.M. Camargo P.V. Borges F.K. Rossini A.P. Polanczyk C.A. Prognostic value of myeloperoxidase in coronary artery disease: Comparison of unstable and stable angina patients. Coron. Artery Dis. 2010 21 3 129 136 10.1097/MCA.0b013e328333f50d 20305551
    [Google Scholar]
  38. Tudurachi B.S. Anghel L. Tudurachi A. Sascău R.A. Stătescu C. Assessment of inflammatory hematological ratios (NLR, PLR, MLR, LMR and Monocyte/HDL–Cholesterol Ratio) in acute myocardial infarction and particularities in young patients. Int. J. Mol. Sci. 2023 24 18 14378 10.3390/ijms241814378 37762680
    [Google Scholar]
  39. Yuan S. Li L. Pu T. Fan X. Wang Z. Xie P. Li P. The relationship between NLR, LDL-C/HDL-C, NHR and coronary artery disease. PLoS One 2024 19 7 e0290805 10.1371/journal.pone.0290805 38985788
    [Google Scholar]
  40. Gosav E.M. Tanase D.M. Buliga-Finis O.N. Rezuș I.I. Morariu P.C. Floria M. Rezus C. The prognostic role of the neutrophil-to-lymphocytes ratio in the most frequent cardiovascular diseases: An update. Life 2024 14 8 985 10.3390/life14080985 39202727
    [Google Scholar]
  41. Guasti L. Castiglioni L. Maroni L. Marino F. Squizzato A. Ageno W. Gianni M. Gaudio G. Grandi A. Cosentino M. Venco A. Dentali F. Neutrophils and clinical outcomes in patients with acute coronary syndromes and/or cardiac revascularisation. Thromb. Haemost. 2011 106 10 591 599 10.1160/TH11‑02‑0096 21866299
    [Google Scholar]
  42. Wang X. Zhang G. Jiang X. Zhu H. Lu Z. Xu L. Neutrophil to lymphocyte ratio in relation to risk of all-cause mortality and cardiovascular events among patients undergoing angiography or cardiac revascularization: A meta-analysis of observational studies. Atherosclerosis 2014 234 1 206 213 10.1016/j.atherosclerosis.2014.03.003 24681815
    [Google Scholar]
  43. Easmin T. Khalequzzaman M. Ahmed M. Hasan M.M. Association Between Neutrophil to Lymphocyte Ratio and Severity of Coronary Artery Disease in Acute Myocardial Infarction Patients Association between neutrophil to lymphocyte ratio and severity of coronary artery disease in acute myocardial infarction patients. Bangladesh Heart J. 2024 39 1 1 9 10.3329/bhj.v39i1.70655
    [Google Scholar]
  44. Zahorec R. Neutrophil-to-lymphocyte ratio, past, present and future perspectives. Bratisl. Med. J. 2021 122 7 474 488 10.4149/BLL_2021_078 34161115
    [Google Scholar]
  45. Yazgan B. Sozen E. Karademir B. Ustunsoy S. Ince U. Zarkovic N. Ozer N.K. CD36 expression in peripheral blood mononuclear cells reflects the onset of atherosclerosis. Biofactors 2018 44 6 588 596 10.1002/biof.1372 28677864
    [Google Scholar]
  46. Sozen E. Yazgan B. Sahin A. Ince U. Ozer N.K. High cholesterol diet‐induced changes in Oxysterol and scavenger receptor levels in heart tissue. Oxid. Med. Cell. Longev. 2018 2018 1 8520746 10.1155/2018/8520746 30008986
    [Google Scholar]
  47. Bozaykut P. Karademir B. Yazgan B. Sozen E. Siow R.C.M. Mann G.E. Ozer N.K. Effects of vitamin E on peroxisome proliferator-activated receptor γ and nuclear factor-erythroid 2-related factor 2 in hypercholesterolemia-induced atherosclerosis. Free Radic. Biol. Med. 2014 70 174 181 10.1016/j.freeradbiomed.2014.02.017 24583459
    [Google Scholar]
  48. Reynolds J.C. Lai R.W. Woodhead J.S.T. Joly J.H. Mitchell C.J. Cameron-Smith D. Lu R. Cohen P. Graham N.A. Benayoun B.A. Merry T.L. Lee C. MOTS-c is an exercise-induced mitochondrial-encoded regulator of age-dependent physical decline and muscle homeostasis. Nat. Commun. 2021 12 1 470 10.1038/s41467‑020‑20790‑0 33473109
    [Google Scholar]
  49. Yang Y. Gao H. Zhou H. Liu Q. Qi Z. Zhang Y. Zhang J. The role of mitochondria-derived peptides in cardiovascular disease: Recent updates. Biomed. Pharmacother. 2019 117 109075 10.1016/j.biopha.2019.109075 31185388
    [Google Scholar]
  50. Kim S.J. Mehta H.H. Wan J. Kuehnemann C. Chen J. Hu J.F. Hoffman A.R. Cohen P. Mitochondrial peptides modulate mitochondrial function during cellular senescence. Aging 2018 10 6 1239 1256 10.18632/aging.101463 29886458
    [Google Scholar]
  51. Lee C. Kim K.H. Cohen P. MOTS-c: A novel mitochondrial-derived peptide regulating muscle and fat metabolism. Free Radic. Biol. Med. 2016 100 182 187 10.1016/j.freeradbiomed.2016.05.015 27216708
    [Google Scholar]
  52. Mendelsohn A.R. Larrick J.W. Mitochondrial-derived peptides exacerbate senescence. Rejuvenation Res. 2018 21 4 369 373 10.1089/rej.2018.2114 30058454
    [Google Scholar]
  53. Zhai D. Ye Z. Jiang Y. Xu C. Ruan B. Yang Y. Lei X. Xiang A. Lu H. Zhu Z. Yan Z. Wei D. Li Q. Wang L. Lu Z. MOTS-c peptide increases survival and decreases bacterial load in mice infected with MRSA. Mol. Immunol. 2017 92 151 160 10.1016/j.molimm.2017.10.017 29096170
    [Google Scholar]
  54. Tang M. Su Q. Duan Y. Fu Y. Liang M. Pan Y. Yuan J. Wang M. Pang X. Ma J. Laher I. Li S. The role of MOTS-c-mediated antioxidant defense in aerobic exercise alleviating diabetic myocardial injury. Sci. Rep. 2023 13 1 19781 10.1038/s41598‑023‑47073‑0 37957221
    [Google Scholar]
  55. Hill S. Sataranatarajan K. Van Remmen H. Role of signaling molecules in mitochondrial stress response. Front. Genet. 2018 9 225 10.3389/fgene.2018.00225 30042784
    [Google Scholar]
  56. Camici P.G. Crea F. Coronary microvascular dysfunction. N. Engl. J. Med. 2007 356 8 830 840 10.1056/NEJMra061889 17314342
    [Google Scholar]
  57. Crea F. Camici P.G. Bairey Merz C.N. Coronary microvascular dysfunction: An update. Eur. Heart J. 2014 35 17 1101 1111 10.1093/eurheartj/eht513 24366916
    [Google Scholar]
  58. Niccoli G. Scalone G. Lerman A. Crea F. Coronary microvascular obstruction in acute myocardial infarction. Eur. Heart J. 2016 37 13 1024 1033 10.1093/eurheartj/ehv484 26364289
    [Google Scholar]
  59. Rochette L. Rigal E. Dogon G. Malka G. Zeller M. Vergely C. Cottin Y. Mitochondrial-derived peptides: New markers for cardiometabolic dysfunction. Arch. Cardiovasc. Dis. 2022 115 1 48 56 10.1016/j.acvd.2021.10.013 34972639
    [Google Scholar]
  60. Bolignano D. Greco M. Presta P. Duni A. Zicarelli M. Mercuri S. Pappas E. Lakkas L. Musolino M. Naka K.K. Misiti R. Foti D.P. Andreucci M. Coppolino G. Dounousi E. The mitochondrial-derived peptide MOTS-c may refine mortality and cardiovascular risk prediction in chronic hemodialysis patients: A multicenter cohort study. Blood Purif. 2024 53 10 824 837 10.1159/000540303 39111290
    [Google Scholar]
  61. Asil H. Demiryürek A.T. Düzen I.V. Büyükcelebi O. Saracaloglu A. Demirkiran C. Demiryürek Ş. Effects of empagliflozin and dapagliflozin on serum humanin, MOTS-c levels, nitrosative stress, and ferroptosis parameters in diabetic patients with heart failure. Eur. J. Pharmacol. 2024 982 176934 10.1016/j.ejphar.2024.176934 39182552
    [Google Scholar]
/content/journals/chamc/10.2174/0118715257368076250324041741
Loading
/content/journals/chamc/10.2174/0118715257368076250324041741
Loading

Data & Media loading...


  • Article Type:
    Research Article
Keywords: troponin I ; myocardial infarction ; inflammation ; Cardiovascular diseases ; MOTS-c ; MDPs
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test